How effective is Upadacitinib in treating Crohn's disease?

Upadacitinib is indicated for the treatment of adult patients with moderately to severely active Crohn's disease who have an inadequate response to or are intolerant to one or moreTNF blockers. It is not recommended to use upadatinib in combination with other JAKinhibitors, biological therapies for Crohn's disease, or strong immunosuppressives (such as azathioprine and cyclosporine).

Two major studies involving 1,021 patients with moderately to severely active Crohn's disease show that upatatinib is effective in improving disease symptoms. During the 12 weeks of treatment, patients took upadatinib 45 once daily. mg or placebo. In both studies, symptoms were gone or nearly gone in 40% and 51% of patients taking upapatinib, respectively, compared with 14% and 22% of patients taking placebo. Intestinal inflammation was reduced by more than half in 35% and 46% of patients who took upatinib, compared with 4% and 13% of those who took placebo.

The third study involved 502 patients with Crohn's disease whose Crohn's disease improved with upatinib from the first two studies. Patients received 15 or 30mg of the drug or a placebo daily. After 52 weeks of treatment, 36%of patients taking 15 mg upatinib had or nearly disappeared from their Crohn's disease symptoms who took 30 mg Forty-six percent of patients who took upapatinib had their Crohn's disease symptoms disappear or nearly disappear, compared with 14% of patients who took placebo. 28% and 40% of patients taking upatinib 15 mg and 30 mg respectively.Intestinal inflammation was reduced by more than half in patients, compared with only 7% of patients taking a placebo. There are generic drugs in Bangladesh, the retail price is more than 15mg for 30 tablets7 more than 100. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to learn more about high-quality overseas drugs for you.